CKBP-002

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameCKBP-002

Drug Alias NameRaf/MEK/Erk pathway inhibitor (CK Life Sciences)Raf/MEK/Erk pathway inhibitor (CK Life Sciences)Cucurbitacin BCKBP-002

ClassificationSmall moleculesNatural product/Extract

Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase modulatorsSignal transducer and activator of transcription 3 inhibitorsSerine/threonine-protein kinase A-Raf modulators

TargetsSerine/threonine-protein kinase A-RafDual specificity mitogen-activated protein kinase kinaseSignal transducer and activator of transcription 3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCk Life Sciences Int'L (Holdings) Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCk Life Sciences Int'L (Holdings) Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A